Literature DB >> 27784625

Nicotine-induced neuroplasticity counteracts the effect of schizophrenia-linked neuregulin 1 signaling on NMDAR function in the rat hippocampus.

Yoshihiko Yamazaki1, Katumi Sumikawa2.   

Abstract

A high rate of heavy tobacco smoking among people with schizophrenia has been suggested to reflect self-medication and amelioration of cognitive dysfunction, a core feature of schizophrenia. NMDAR hypofunction is hypothesized to be a mechanism of cognitive dysfunction, and excessive schizophrenia-linked neuregulin 1 (NRG1) signaling through its receptor ErbB4 can suppress NMDAR function by preventing Src-mediated enhancement of NMDAR responses. Here we investigated whether chronic nicotine exposure in rats by subcutaneous injection of nicotine (0.5-1 mg/kg, twice daily for 10-15 days) counteracts the suppressive effect of NRG1β on NMDAR-mediated responses recorded from CA1 pyramidal cells in acute hippocampal slices. We found that NRG1β, which prevents the enhancement of NMDAR responses by the Src-family-kinase-activating peptide pYEEI in naive rats, failed to block the effect of pYEEI in nicotine-exposed rats. In naive rats, NRG1β acts only on GluN2B-NMDARs by blocking their Src-mediated upregulation. Chronic nicotine exposure causes enhanced GluN2B-NMDAR responses via Src upregulation and recruits Fyn for the enhancement of GluN2A-NMDAR responses. NRG1β has no effect on both enhanced basal GluN2B-NMDAR responses and Fyn-mediated enhancement of GluN2A-NMDAR responses. Src-mediated enhancement of GluN2B-NMDAR responses and Fyn-mediated enhancement of GluN2A-NMDAR responses initiate long-term potentiation (LTP) of AMPAR synaptic responses in naive and nicotine-exposed CA1 pyramidal cells, respectively. These results suggest that NRG1β suppresses LTP by blocking Src-mediated enhancement of GluN2B-NMDAR responses, but has no effect on LTP in nicotine-exposed rats. These effects of chronic nicotine exposure may counteract the negative effect of increased NRG1-ErbB4 signaling on the cellular mechanisms of learning and memory in individuals with schizophrenia, and therefore may motivate heavy smoking. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fyn; GluN2A; GluN2B; Neuregulin 1; Nicotine; Src

Mesh:

Substances:

Year:  2016        PMID: 27784625      PMCID: PMC5148721          DOI: 10.1016/j.neuropharm.2016.10.021

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  49 in total

Review 1.  NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity.

Authors:  D W Ali; M W Salter
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

Review 2.  Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.

Authors:  Justin W Kenney; Thomas J Gould
Journal:  Mol Neurobiol       Date:  2008-08-09       Impact factor: 5.590

3.  PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.

Authors:  T Tezuka; H Umemori; T Akiyama; S Nakanishi; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  A Src link in schizophrenia.

Authors:  Chang-Gyu Hahn
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

5.  The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders.

Authors:  Alon Shamir; Oh-Bin Kwon; Irina Karavanova; Detlef Vullhorst; Elias Leiva-Salcedo; Megan J Janssen; Andres Buonanno
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

6.  Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Authors:  Graham M Pitcher; Lorraine V Kalia; David Ng; Nathalie M Goodfellow; Kathleen T Yee; Evelyn K Lambe; Michael W Salter
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

7.  Association of PSD-95 with ErbB4 facilitates neuregulin signaling in cerebellar granule neurons in culture.

Authors:  Fang Xie; Mallika Padival; Ruth E Siegel
Journal:  J Neurochem       Date:  2006-10-27       Impact factor: 5.372

8.  NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia.

Authors:  Melissa A Snyder; Wen-Jun Gao
Journal:  Front Cell Neurosci       Date:  2013-03-27       Impact factor: 5.505

Review 9.  Molecular targets for treating cognitive dysfunction in schizophrenia.

Authors:  John A Gray; Bryan L Roth
Journal:  Schizophr Bull       Date:  2007-07-07       Impact factor: 7.348

Review 10.  GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity.

Authors:  Olivia A Shipton; Ole Paulsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

View more
  1 in total

1.  Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats.

Authors:  Dalia A Nawwar; Hala F Zaki; Rabab H Sayed
Journal:  Inflammopharmacology       Date:  2022-07-25       Impact factor: 5.093

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.